Growth Metrics

Quest Diagnostics (DGX) Cash & Current Investments (2016 - 2026)

Quest Diagnostics has reported Cash & Current Investments over the past 18 years, most recently at $393.0 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 109.04% to $393.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $393.0 million through Mar 2026, up 109.04% year-over-year, with the annual reading at $420.0 million for FY2025, 23.5% down from the prior year.
  • Cash & Current Investments was $393.0 million for Q1 2026 at Quest Diagnostics, down from $420.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $790.0 million in Q2 2022 and troughed at $126.0 million in Q2 2023.
  • The 5-year median for Cash & Current Investments is $420.0 million (2025), against an average of $438.6 million.
  • Biggest five-year swings in Cash & Current Investments: crashed 84.05% in 2023 and later surged 434.27% in 2024.
  • Tracing DGX's Cash & Current Investments over 5 years: stood at $315.0 million in 2022, then skyrocketed by 117.78% to $686.0 million in 2023, then decreased by 19.97% to $549.0 million in 2024, then dropped by 23.5% to $420.0 million in 2025, then fell by 6.43% to $393.0 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $393.0 million, $420.0 million, and $432.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.